Definiens, The Tissue Phenomics Company

We improve patient lives by unlocking the tissue phenome. In oncology, therapeutic strategies have shifted from a direct assault on cancer cells to recruiting the immune system for that purpose. Our mission is to accelerate breakthroughs for this approach by helping scientists leverage Tissue Phenomics to deepen understanding of disease biology and immune system mechanisms, to bring multi-omics data into a cancer-relevant context, and to facilitate the translation of new insights into novel therapies and treatment strategies. Our vision is to create unique patient profiles for an individualized standard of care, where patients experience fewer side effects and live longer....

Biomedical image analysis software,drug discovery and development,digital pathology,translational research,tissue diagnostics,companion diagnostics,oncology,automated image analysis,data mining,tissue-based biomarkers,clinical trials,and clinical diagnostics

Definiens, the tissue phenomics company operates in the Biotechnology research industry.

Definiens, the tissue phenomics company's revenue is 11m - 100m

Definiens, the tissue phenomics company has 11 - 50 employees.